114 related articles for article (PubMed ID: 1718694)
1. Intrarenal infusion of gallopamil in acute renal failure. A preliminary report.
Lumlertgul D; Wongmekiat O; Sirivanichai C; Hundagoon P; Keoplung M; Conger JD; Schrier RW
Drugs; 1991; 42 Suppl 1():44-50. PubMed ID: 1718694
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effect of intrarenal verapamil in human acute renal failure.
Lumlertgul D; Hutdagoon P; Sirivanichai C; Keoplung M; Wongmekiat O; Nitsin S; Sangchun G
Ren Fail; 1989-1990; 11(4):201-8. PubMed ID: 2485483
[TBL] [Abstract][Full Text] [Related]
3. Effect of intrarenal furosemide on renal function and intratenal hemodynamics in acute renal failure.
Epstein M; Schneider NS; Befeler B
Am J Med; 1975 Apr; 58(4):510-6. PubMed ID: 1124788
[TBL] [Abstract][Full Text] [Related]
4. Torsemide versus furosemide after continuous renal replacement therapy due to acute renal failure in cardiac surgery patients.
Vargas Hein O; Staegemann M; Wagner D; von Heymann C; Martin M; Morgera S; Spies C
Ren Fail; 2005; 27(4):385-92. PubMed ID: 16060124
[TBL] [Abstract][Full Text] [Related]
5. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
Mahesh B; Yim B; Robson D; Pillai R; Ratnatunga C; Pigott D
Eur J Cardiothorac Surg; 2008 Mar; 33(3):370-6. PubMed ID: 18243724
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
Ng TM; Hshieh S; Chan CY; Elkayam U
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
[TBL] [Abstract][Full Text] [Related]
7. Synergism of dopamine and furosemide in diuretic-resistant, oliguric acute renal failure.
Lindner A
Nephron; 1983; 33(2):121-6. PubMed ID: 6835459
[TBL] [Abstract][Full Text] [Related]
8. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.
Aziz EF; Alviar CL; Herzog E; Cordova JP; Bastawrose JH; Pamidimukala CK; Tojino A; Park TS; Musat D; Kukin M
Hellenic J Cardiol; 2011; 52(3):227-35. PubMed ID: 21642071
[TBL] [Abstract][Full Text] [Related]
9. Dopamine and frusemide in oliguric acute renal failure.
Graziani G; Cantaluppi A; Casati S; Citterio A; Scalamogna A; Aroldi A; Silenzio R; Brancaccio D; Ponticelli C
Nephron; 1984; 37(1):39-42. PubMed ID: 6717704
[TBL] [Abstract][Full Text] [Related]
10. Furosemide and dopamine in malarial acute renal failure.
Lumlertgul D; Keoplung M; Sitprija V; Moollaor P; Suwangool P
Nephron; 1989; 52(1):40-4. PubMed ID: 2651949
[TBL] [Abstract][Full Text] [Related]
11. High-dose amino acid infusion preserves diuresis and improves nitrogen balance in non-oliguric acute renal failure.
Singer P
Wien Klin Wochenschr; 2007; 119(7-8):218-22. PubMed ID: 17492348
[TBL] [Abstract][Full Text] [Related]
12. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of intrarenal calcium membrane blockers before or after renal ischemia. Functional, morphological, and mitochondrial studies.
Burke TJ; Arnold PE; Gordon JA; Bulger RE; Dobyan DC; Schrier RW
J Clin Invest; 1984 Nov; 74(5):1830-41. PubMed ID: 6501573
[TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
Rogers HL; Marshall J; Bock J; Dowling TC; Feller E; Robinson S; Gottlieb SS
J Card Fail; 2008 Feb; 14(1):1-5. PubMed ID: 18226766
[TBL] [Abstract][Full Text] [Related]
15. Concomitant treatment with urodilatin (ularitide) does not improve renal function in patients with acute renal failure after major abdominal surgery--a randomized controlled trial.
Herbert MK; Ginzel S; Mühlschlegel S; Weis KH
Wien Klin Wochenschr; 1999 Feb; 111(4):141-7. PubMed ID: 10192146
[TBL] [Abstract][Full Text] [Related]
16. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
17. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
18. Determinants of Urinary Output Response to IV Furosemide in Acute Kidney Injury: A Pharmacokinetic/Pharmacodynamic Study.
Silbert BI; Ho KM; Lipman J; Roberts JA; Corcoran TB; Morgan DJ; Pavey W; Mas E; Barden AE; Mori TA
Crit Care Med; 2016 Oct; 44(10):e923-9. PubMed ID: 27183025
[TBL] [Abstract][Full Text] [Related]
19. Furosemide and acute renal failure.
Borirakchanyavat V; Vongsthongsri M; Sitprija V
Postgrad Med J; 1978 Jan; 54(627):30-2. PubMed ID: 625455
[TBL] [Abstract][Full Text] [Related]
20. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
